chrisvoncsefalvay/vaers-outcomes huggingface dataset:
nose felt tingly front teeth and right side of my tongue felt numb; nose felt tingly front teeth and right side of my tongue felt numb; This is a spontaneous report from a contactable consumer (patient herself). A 71-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EL 9263), via an unspecified route of administration in left arm on 22Jan2021 16:15 at single dose for COVID-19 immunisation. The patient's medical history included diabetes, high cholesterol, thyroid, allergies: Sulfites in foods and drugs, allergies: Penicillin. Concomitant medications included metformin at 800 mg, twice a day and levothyroxine sodium (LEVOTHYROXIN) at 75mg, once a day. The patient previously took sulfur and experienced allergies: sulfur. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination. On 22Jan2021, at 16:15, the patient reported nose felt tingly front teeth and right side of my tongue felt numb. The patient carries an epi pen for an allergic reaction as the patient have to sulfites in foods and drugs (sulfur and penicillin allergies). The patient did not have to call for help or use epi-pen but was concerned somewhat for the second dose in 19 days. The events was considered as non-serious by the consumer. When the patient went home about 15 minutes later still felt this, hence the therapeutic measures were taken as a result of events included treatment with 2tbl Benadryl and 1/2 Zertex and within 30 minutes the patient was ok. The outcome of the events was recovered on an unspecified date in Jan2021.
Nausea; Stomach pains/. stomach pains have gotten much worse; Major headache; Body aches; Fatigue; Had typical arm sore; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 13Apr2021 at 10:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 14Apr2021, next morning, the patient experienced typical arm sore then had diarrhea and the patient was good for next 2 days. On 17Apr2021, the patient woke up on Saturday with a major headache then as the day went on body aches and fatigue set in. On 19Apr2021, Monday the patient had started getting stomach pains. On 20Apr2021 (reported as today), the stomach pains had gotten much worse leading to diarrhea and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measure was taken as a result of the headache which included paracetamol (TYLENOL) every 8 hours to control headache and for other events was not taken. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event typical arm sore was resolved on an unknown date in Apr2021; whereas for the events diarrhea, major headache, body aches, fatigue, stomach pains and nausea was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Had pain in arm for several days. Never had any prior problems. Always had the shots. Doctor's office sent me this form. Seem to be OK now.
Initial report received from a non-healthcare professional on 30 JAN 2014. A patient, whose gender, age, medical history and concomitant medications was not reported had received a dose of FLUZONE Quadrivalent (batch number: 04792AA) dose, dose in series, route and site of administration were not reported on 06 JAN 2014. On 08 JAN 2014, two days after vaccination the patient developed hives all over my body. Corrective treatments and laboratory investigations were not reported. The outcome of the events was not reported. Documents held by sender: None.  Additional information was received from the consumer's husband on 30 JAN 2014, which provided contact information for her physician.  The female patient, was 62 at the time of the event, had a history of diabetes, hypertension and arthritis, with allergies in latex, penicillin, azithromycin, sulfa drugs, Nizoral, Lamisil , azasite and "possibly cortisone". Concomitant medications included a cortisone/lidocaine injection in her knee approximately one week prior to vaccination. She received an intramuscular injection of FLUZONE on 06 JAN 2014, and two days post-vaccination began experiencing generalized hives described as "red circles with white/clear centers". She developed redness of her face, neck, and chest, "possibly allergic reaction". She was seen by two physicians and prescribed diphenhydramine, doxepin, levo cetirizine, des loratadine, atrapro  gel, clobetasol propionate and triamcinolone cream. She was also instructed to avoid eggs. According to the reporter, the patient continued to experience generalized hives and further testing was planned. The patient had not recovered at the time of this report.
10 minutes following vaccine administration and during a venous blood draw, client became pale and fainted. Client was laid on exam bed-had been in sitting position.  She lost consciousness for 30 seconds. When client came to, resting BP was 110/58 and HR 56 @ 1330. Client alert and oriented.
Case number PHEH2014US025124, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 66-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 21 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration (incorrect storage of drug).
Cough, fever, muscle and bone pain, headache.  5 day course of Paxlvid.
Bilateral deltoid muscle sites: pain, swelling and redness. Now no fever, pain 3/10. Treatment by PA: BACTRIM DS 1 BID - 10 days.
Itchy arm/it was itchier; red circle of around 4 inches; arm was a little swollen; Covid arm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy arm/it was itchier), ERYTHEMA (red circle of around 4 inches), PERIPHERAL SWELLING (arm was a little swollen) and VACCINATION SITE RASH (Covid arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     Concurrent medical conditions included Seafood allergy (shrimp). Concomitant products included VITAMIN D NOS, VITAMIN B NOS, VITAMIN E NOS, ATORVASTATIN CALCIUM (LIPITOR), HYDROCHLOROTHIAZIDE and ALENDRONATE SODIUM (FOSAMAX) for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itchy arm/it was itchier), ERYTHEMA (red circle of around 4 inches), PERIPHERAL SWELLING (arm was a little swollen) and VACCINATION SITE RASH (Covid arm). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1 dosage form. At the time of the report, PRURITUS (Itchy arm/it was itchier), ERYTHEMA (red circle of around 4 inches), PERIPHERAL SWELLING (arm was a little swollen) and VACCINATION SITE RASH (Covid arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow Up received on 14-JUL-2021. The reporter contact details were updated.
syncopal event, immediately after vaccine. fell forward and hit forehead on the ground, brief myoclonus and then took 30-45 minutes to recover and to be able to leave clinic. follow up by phone later in the day. patient was feeling better and was able to go to play practice. goose egg on forehead had gone down with ice. no concussion symptoms
Hair Loss.  Balding spot on left side of head and thinning on top.  This occurred after shot 2 but hair was growing back.  Occurred again after third shot in same area.
Information has been received from a registered nurse concerning a female pt who on 8/28/02 was vaccinated with a dose of MMR II, "at which time the pt stated she was not pregnant." It was noted that the "pt called and reported that she was pregnant when she received the immunization." On 11/14/02, "one of the nurses called the pt and the pt reported she had a miscarriage." The cause of death was miscarriage. The nurse also reported on another pt who received varicella vaccine live during pregnancy (WAES0205USA02764). Additional info has been requested.
Monovalent mRNA vaccine administered for a bivalent mRNA dose.   We had not been notified (as of date of this vaccine  administration)  that monovalent vaccine had been discontinued). Notice wasn't released until 05-01-2023, sent via e-mail to my supervisor on 05-02-2023,  forwarded to me, where I read it the morning of  05-03-2023 at which time, then all remaining doses of monovalent mRNA vaccine was destroyed.  This patient had no adverse effects or event as result of this dose of vaccine given.  This patient was released from our custody and transferred on 05/12/2023.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. There were no information about patient's concomitant medications and pertinent medical history reported. In August 2012, the patient was vaccinated with the first dose of GARDASIL (dose, site, route of administration, lot# and expiry date were not reported). In August 2013, the patient was vaccinated with the second dose of GARDASIL (dose, site, route of administration, lot# and expiry date were not reported). On 08-SEP-2015, the patient was in the office to receive the third dose of GARDASIL (dose, site, route of administration, lot# and expiry date were not reported) but it was not reported if the patient received this dose. No adverse effects were reported. Additional information has been requested.
pt recv vax 26JAN99 & on 10FEB99 had diff in walking, slow speech, uncoordination, dysarthria dx w/MS on 3SEP97; had sx of rt facial weakness, hypesthesia rt face;dx w/disseminated encephalomyelitis;
This case was reported by a medical representative via call center representative and described the occurrence of axillary lump in a adult female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced axillary lump and contusion. On an unknown date, the outcome of the axillary lump and contusion were unknown. It was unknown if the reporter considered the axillary lump and contusion to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient over 60 years of age received SHINGRIX and experienced a lump under her arm in the armpit area with bruising. No other specifics were known. The nurse did not want to follow up.
Patient presents after a fall at home. Lightheadedness, weakness and now with confirmed positive COVID-19 infection. Fortunately, his vital signs have been stable. He is saturating well on room air. However, weakness in the setting of the infection likely resulted in the fall.
This was my booster shot and it?s important to note I had the same reaction in my 2 dose series on 04/21/21.  My symptoms included full body muscular spasms. It felt like I was being electrocuted. It felt like I had Charlie horses, shin splints, and severe growing pains in my legs to start and then progresses throughout my body. Muscles I have never felt before were spasming and throbbing including my inner ear canal.   On the night that I got the vaccine I broke out in full body tremors for an hour from 12:00am to 1:00am (12/4/21 technically). I?ve never had tremors or anything like that before.   My arms had such intense pain and I my fingers were getting stuck and unable to bend. The only thing that made me feel better was intense compression I tried to squeeze my arms as hard as I could.   At one point on the afternoon of 12/4/21 I got up from bed and had an intense stabbing spasm pain in my mid back and it shot down my legs and it caused me to buckle my knees and fall into a wall.   I was deeply uncomfortable in my own skin - I wasn?t able to get comfortable by any means. I was able to take a prescribed muscle relaxer to help me get to sleep.   Then on the night of 12/4 into 12/5 I sweated through my pajamas and woke up at 3am and had to change. It was like I showered. That lasted until I re awoke at 9:30am.  Now on 12/5/21 I feel fine with some residual soreness from the constant spasming and feelings of being electrocuted. My body just feels beat up.
PER PATIENT: "I BROKE OUT IN RASH ROUGHLY 6 HOURS AFTER VACCINATION ON MY NECK, HANDS, ARMS, CHEST, STOMACH. TREATED WITH AN OTC ANTIHISTAMINE AND LOTION. RASH LASTED ~48 HOURS AND ITCHINESS ALL OVER BODY LASTED X 1 WEEK."
CoughWheeze cough & loss of apptite which has returned  Patient reports self - treating: "I've just been taking Tylenol 500mg once day, for the whole day & I took one Ibuprofen  yesterday and the Tylenol at night."
Pt called the office on 2/11/2011 reports developed acute onset chills, headache shaking at aforementioned date & time with cough. Additionally reports low grade temp 99. States recovering.
Client was given injection. Approximately 5 minutes later mother called us over as he was lethargic and not feeling well. He blacked out and got pale and sweaty. Heart rate and blood pressure dropped. Developed a rash on the face, neck, and trunk. Ambulance was called. Helped client to the ground. Applied cold wash cloth to the back othe neck. Got water. Monitoed vitals. Ambulance arrived and report given. Client taken to the ER.
4-6hr p/vax pt stated began to chill & ache;progressed to fever 101, n/v, body aches & insomnia;acute s&s x 2 days then gradually improved;felt better by day 4 p/vax given;seen by MD;dx flu-like sx probably d/t vax & also dx pharyngitis;
When I got the vaccine I felt a cramp which did not go away.  Approximately minutes after 6pm my arm felt weird.  I looked at my arm and noticed the swelling.  The swelling was noticeable from my elbow down to my wrist.  The cramp was on and off.  I measured my arm and the measurement immediately below the elbow was 1.5 inch more than my right elbow and the measurement at my wrist was .75 inch more that the right wrist.  I did not experience any pain in the swollen area only at the injection site.  The next day there was no changes in the swelling. On 1/2/23  noticed the swelling is going down not has not gotten to the original size.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61-year-old male patient received BNT162b2 (BNT162B2), on 26Mar2021 at 12:30 as dose 1, single (Lot number: ER8733), in left arm and on 17Apr2021 at 10:00 as dose 2, single (Lot number: ER8735) at the age of 60 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 18Nov2021 at 09:45 as dose 3 (booster), single (Lot number: 006D21A), in right arm for covid-19 immunisation. The patient's relevant medical history included: "GERD" (unspecified if ongoing); "Moderate Cholesterol" (unspecified if ongoing), notes: Moderate Cholesterol; "Dose 1, 2 - Pfizer/ Dose 3 - Moderna" (unspecified if ongoing), notes: Dose 1, 2 - Pfizer/ Dose 3 - Moderna. Concomitant medication(s) included: SIMVASTATIN, start date: 01Jan2018, stop date: 28Apr2022; LANSOPRAZOLE, start date: 01Jan2019, stop date: 28Apr2022. The following information was reported: VACCINATION FAILURE (medically significant) with onset Apr2022, outcome "unknown", COVID-19 (medically significant) with onset Apr2022, outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Apr2022) positive, notes: Tested positive; (13May2022) positive, notes: Tested positive again. Therapeutic measures were taken as a result of covid-19.  No follow-up attempts are possible. No further information is expected.
left arm: sore, warm, swollen, redness drowsiness gradually intensifying headache fever 101 neck pain, tightness back pain, soreness elevated blood sugars uterine cramps restless legs
Within 5-10 minutes of receiving vax, pt returned to MD's office with hives of face and neck. Pt had no shortness of breath, wheezing or dysphagia.
Pt vaccinated w/Recombivax doses 1 & 2; Following 1st dose pain @ inject site; 2nd dose experienced prolonged pain & tenderness @ inject site;
After the first dose I had nausea and headaches. Both worsened after 2nd dose; I can't eat a whole lot or sleep; I can't eat a whole lot or sleep; Everything has a funny taste to it/taste like pennies/it has a metallic taste/It's like when orange juice mixes with toothpaste/a nasty taste; My sinus is swollen too; After the first dose I had nausea and headaches. Both worsened after 2nd dose; My voice is raspy; had some diarrhea; This is a spontaneous report from a contactable consumer (Patient). A 34-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), Solution for injection, via an unspecified route of administration on 03Jun2021 as 2nd dose, single dose for covid-19 immunisation. Medical history included, vomiting from. The patient's concomitant medications were not reported. Patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) received on 13-MAY-2021 and experienced nausea and headache. On an unspecified date in Jun2021, the patient experienced bad nausea, can't eat a whole lot or sleep, everything had a funny taste to it/taste like pennies/it had a metallic taste/it was like when orange juice mixes with toothpaste/a nasty taste, sinus was swollen too, headaches, voice was raspy and had some diarrhea. Patient had side effects that was not on the pamphlet she received. She received first dose on 13MAY and 2nd dose 3Jun2021. She had bad nausea, to top it off she could not eat a whole lot or sleep. Everything had a funny taste to it. taste like pennies. It did not matter what it was (it had a metallic taste; drink/liquids too). It was like when orange juice mixes with toothpaste. a nasty taste. she did have headaches when she got it initially. After the first dose she had nausea and headaches. Both worsened after 2nd dose (more with the nausea headaches was not too too bad). The nausea was unbearable. She had nausea after first shot; worsen with the 2nd one. Her voice was raspy. Her sinus was swollen too. She had vomiting before the covid vaccine when she gave blood. It had been over 3 weeks of being nauseous. She wanted to know if she should get a covid test done? She told that, she got a front and back information sheet. Not everyone was getting the same information; that needed to be corrected. Her cousin asked her about different things. Her paper was about wearing masks only have information on side effects: fever, diarrhea. She had no fever; had nausea (which wasn't mentioned on her information sheet). Even when she asked the nurse about it, she told her fever but not nausea. We all don't have the same reactions as others. She had some diarrhea. This nausea was annoying. The pamphlet they gave were different depending on clinic/site. She didn't get the same information sheet. The outcome of events was unknown.   Information about lot/batch number is requested.
This case was reported by a nurse and described a male patient in his 40's who did not respond to Hep-B vaccine.   On an unspecified date in 2004 the patient received the third dose of Energix-B.  On an unspecified date in SEP 2004, a Hep-B surface antibody titer was "negative".  The reporting nurse considered the event to probably be related to vaccination with Energix-B
Flu like symptoms. Headache, glands in neck sore.  Nausea and diarrhea, fatigue
A report has been received from a Health Professional concerning a patient, Female subject, who had been receiving Nasal FLUMIST Quadrivalent (Intranasal), 0.2 Millilitres. FLUMIST Quadrivalent (Intranasal) started on 06-Jan-2016. It was reported that a dose of expired FLUMIST was administered. FLUMIST Quadrivalent (Intranasal) was continued. The outcome of the event of expired FLUMIST was administered-medication error is unknown. The report was considered to be non-serious.
Period irregularity; Menstrual cycle was extremely heavier and more painful (in intensity & duration) than normal; Menstrual cycle was extremely heavier and more painful (in intensity & duration) than normal; "My" cycle is always regular and consistent, so this was abnormal; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 16Apr2021 at 11:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any concomitant medications. On 25Apr2021, the patient experienced period irregularity, menstrual cycle was extremely heavier and more painful (in intensity and duration) than normal. The patient's cycle was always regular and consistent, so that was abnormal. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events period irregularity, menstrual cycle was extremely heavier and more painful (in intensity and duration) than normal and "my" cycle is always regular and consistent, so this was abnormal was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
I had fatigue, body ache, and nausea. I was dizzy upon standing. These lasted for about 3 days. I went to urgent care about these issues. They did strep test and COVID-19 test, negative results.